![](/images/graphics-bg.png)
Dramatic Response of Nail Psoriasis to Infliximab
Joint Authors
Source
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-05-10
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Nail psoriasis, affecting up to 50% of psoriatic patients, is an important cause of serious psychological and physical distress.
Traditional treatments for nail psoriasis, which include topical or intralesional corticosteroids, topical vitamin D analogues, photochemotherapy, oral retinoids, methotrexate, and cyclosporin, can be time-consuming, painful, or limited by significant toxicities.
Biological agents may have the potential to revolutionize the management of patients with disabling nail psoriasis.
We present another case of disabling nail psoriasis that responded dramatically to infliximab.
American Psychological Association (APA)
Safa, Gilles& Darrieux, Laure. 2011. Dramatic Response of Nail Psoriasis to Infliximab. Case Reports in Medicine،Vol. 2011, no. 2011, pp.1-3.
https://search.emarefa.net/detail/BIM-447013
Modern Language Association (MLA)
Safa, Gilles& Darrieux, Laure. Dramatic Response of Nail Psoriasis to Infliximab. Case Reports in Medicine No. 2011 (2011), pp.1-3.
https://search.emarefa.net/detail/BIM-447013
American Medical Association (AMA)
Safa, Gilles& Darrieux, Laure. Dramatic Response of Nail Psoriasis to Infliximab. Case Reports in Medicine. 2011. Vol. 2011, no. 2011, pp.1-3.
https://search.emarefa.net/detail/BIM-447013
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-447013